PMV PHARMACEUTICALS INC has a total of 13 patent applications. It decreased the IP activity by 77.0%. Its first patent ever was published in 2017. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are KYN THERAPEUTICS, Orion Ophthalmology LLC and REGENACY PHARMACEUTICALS LLC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 3 | |
#2 | WIPO (World Intellectual Property Organization) | 2 | |
#3 | Australia | 1 | |
#4 | Brazil | 1 | |
#5 | Canada | 1 | |
#6 | China | 1 | |
#7 | EPO (European Patent Office) | 1 | |
#8 | Israel | 1 | |
#9 | Republic of Korea | 1 | |
#10 | Mexico | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Heterocyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Li Hongju | 10 |
#2 | Dominique Romyr | 10 |
#3 | Vu Binh | 10 |
#4 | Hongju Li | 2 |
#5 | Romyr Dominique | 2 |
#6 | Binh Vu | 2 |
#7 | Fahr Bruce | 1 |
#8 | Good Andrew | 1 |
Publication | Filing date | Title |
---|---|---|
WO2021061643A1 | METHODS AND COMPOUNDS FOR RESTORING MUTANT p53 FUNCTION | |
EP3416638A1 | METHODS AND COMPOUNDS FOR RESTORING MUTANT p53 FUNCTION |